PPA
TPST icon

Parametric Portfolio Associates’s Tempest Therapeutics TPST Stock Holding History

Parametric Portfolio Associates’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-14
Closed -$286K – 3805
2016
Q3 		$286K Buy
14
+1
+8% +$18.1K ﹤0.01% 3438
2016
Q2 		$205K Buy
13
+1
+8% +$22.8K ﹤0.01% 3595
2016
Q1 		$336K Buy
12
+3
+33% +$63.4K ﹤0.01% 3543
2015
Q4 		$243K Buy
+9
New +$297K ﹤0.01% 3648
2015
Q3 		– Sell
-6
Closed -$480K – 3328
2015
Q2 		$480K Buy
6
+1
+20% +$91.6K ﹤0.01% 3306
2015
Q1 		$507K Sell
5
-1
-17% -$133K ﹤0.01% 3250
2014
Q4 		$729K Hold
6
– – ﹤0.01% 3021
2014
Q3 		$275K Buy
+6
New +$210K ﹤0.01% 3498

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parametric Portfolio Associates's TPST Position: Q4 2016 in Review

Parametric Portfolio Associates sold out of Tempest Therapeutics (TPST) in Q4 2016, closing a stake of 14 shares — an estimated $286K sold.

Parametric Portfolio Associates first reported a position in TPST in Q3 2014 and held it in 8 quarters. The position peaked at $729K in Q4 2014. 84 funds tracked by Wall St. Rank hold TPST as of Q4 2016.

  • Parametric Portfolio Associates reported no remaining Tempest Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Parametric Portfolio Associates sold 14 Tempest Therapeutics shares in Q4 2016, an estimated $286K.
  • Parametric Portfolio Associates first reported a position in Tempest Therapeutics in Q3 2014 and held it in 8 quarters.
  • Parametric Portfolio Associates's Tempest Therapeutics position peaked at $729K in Q4 2014.
  • 84 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2016.

Based on Parametric Portfolio Associates's 13F filing for Q4 2016, filed 14 Feb 2017.